Preview

The Russian Archives of Internal Medicine

Advanced search

Pure Adenocarcinoma with Intestinal Differentiation of The Testis as The First Presentation of a Testicular Teratoma: A Case Report with Literature Review of Management

https://doi.org/10.20514/2226-6704-2026-16-2-137-144

EDN: RXLWMO

Abstract

Pure adenocarcinoma is a somatic-type malignancy that comes from a germ cell tumor and is extremely rare but has been reported. It is usually seen as sarcoma, and less often as carcinoma. This rare phenomenon is generally attributed to the development of a teratomatous component. In most cases, the diagnosis remains straightforward due to the mixing of different germ cell tumor parts and the existence of germ cell neoplasia in situ (GCNIS). But, there are some rare instances where metastatic carcinoma to the testis could be something more. This case presentation discusses a 35-year-old man who had a testicular tumor of adenocarcinoma with enteric features, which looked like metastatic colorectal carcinoma. GCNIS was found in the background testicular tissue, and fluorescence in situ hybridization for chromosome 12p abnormalities showed the presence of i(12p) in the testicular adenocarcinoma, which supports a shared germ cell origin. After the retroperitoneal lymph node dissection, it was found that there were metastatic deposits made up of mucinous adenocarcinoma. Extensive clinical workup helped exclude metastasis from another primary, particularly the GI tract. Our report indicates that adenocarcinoma of intestinal type in an orchiectomy specimen, although usually strongly suggestive of metastasis from a gastrointestinal tract primary, maybe a primary testicular neoplasm of germ cell tumor origin. The patient was treated with radial orchidectomy with retroperitoneal metastasectomy followed by somatic-type malignant histology-directed chemotherapy for colorectal adenocarcinoma. The patient remained in complete remission for a 3.5-years follow-up period.

About the Authors

Najla Saleh Ben Ghashir
Department of Pathology and Laboratory Medicine, Sheikh Shakhbout Medical City
United Arab Emirates

Najla Saleh Ben Ghashir — FRCPath(UK), MBBCh, Consultant Histopathologist, Pathology Section or Pathology and Genetics Department;  Dubai Academic Health Corporation 

Abu Dhabi; Dubai 


Competing Interests:

The authors declare no conflict of interests 



Alingal Mohammed Babitha
Department of Pathology and Laboratory Medicine, Sheikh Shakhbout Medical City
United Arab Emirates

Dr. Babitha Alingal Mohammed — M.D., D.N.B., M.N.A.M.S., F.R.C.Path. (UK), is an anatomic and clinical pathology specialist

Abu Dhabi 


Competing Interests:

The authors declare no conflict of interests 



Aref Chehal
Department of Oncology and Hematooncology, Sheikh Shakhbout Medical City
United Arab Emirates

Aref Chehal — MD, Consultant, Oncology and Hematology Department; Adjunct Professor of Medicine and Oncology

Abu Dhabi 


Competing Interests:

The authors declare no conflict of interests 



Ashraf ALakkad
Department of Internal Medicine, Madinat Zayed Hospital
United Arab Emirates

Ashraf ALakkad — MD, Internist, Department of Internal Medicine, Chair of Antimicrobial Stewardship Program 

Scopus ID: 60052817400, Web Of Science Researcher ID: AEW-9201-2022

AL Dhafra Region 


Competing Interests:

The authors declare no conflict of interests 



References

1. Idrees MT, Ulbright TM, Oliva E, Young RH, Montironi R, Egevad L, et al. The World Health Organization 2016 classification of testicular non-germ cell tumours: A review and update from the International Society of Urological Pathology Testis Consultation Panel. 2017;70(4):513-21.

2. Znaor A, Skakkebaek NE, Rajpert-De Meyts E, Kuliš T, Laversanne M, Gurney J, et al. Global patterns in testicular cancer incidence and mortality in 2020. 2022;151(5):692-8.

3. Williamson SR, Delahunt B, Magi-Galluzzi C, Algaba F, Egevad L, Ulbright TM, et al. The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. 2017;70(3):335-46.

4. Hernández-Reséndiz R, Villanueva-Castro E, Chávez-Macías L, Gómez-Apo E, Ortiz-Plata A, Salinas-Lara C, et al. Teratoma with Malignant ectomesenchymoma in the pineal region: A case report. 2022;14(8).

5. Giannatempo P, Pond GR, Sonpavde G, Albany C, Loriot Y, Sweeney CJ, et al. Treatment and clinical outcomes of patients with teratoma with somatic-type malignant transformation: an international collaboration. 2016;196(1):95-100.

6. Rathore R, Sharma S, Agarwal SJMRPM. Malignant transformation in mature cystic teratoma of the ovary: a retrospective study of eight cases and review of literature. 2018;17(2):63-8.

7. Skapek SX, Ferrari A, Gupta AA, Lupo PJ, Butler E, Shipley J, et al. Rhabdomyosarcoma. 2019;5(1):1.

8. Cong L, Wang S, Yeung SY, Lee JHS, Chung JPW, Chan DYLJIJoMS. Mature cystic teratoma: an integrated review. 2023;24(7):6141.

9. Green DB, La Rosa FG, Craig PG, Khani F, Lam ETJKjor. Metastatic mature teratoma and growing teratoma syndrome in patients with testicular non-seminomatous germ cell tumors. 2021;22(10):1650.

10. Hwang MJ, Hamza A, Zhang M, Tu S-M, Pisters LL, Czerniak B, et al. Somatic-type malignancies in testicular germ cell tumors: a clinicopathologic study of 63 cases. 2022;46(1):11-7.

11. Rosenfeld R, Riondino S, Parisi G, Iannantuono GM, Ajdhoni R, Torino F, et al. Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors. 2024;14:1417776.

12. Li Y, Qin M, Shan Y, Wu H-w, Liu X-d, Yin J, et al. 30-Year experience with 22 cases of malignant transformation arising from ovarian mature cystic teratoma: a rare disease. 2022;12:842703.

13. Tehranian A, Ghahghaei-Nezamabadi A, Seifollahi A, Kasraei S, Dehghani-Nejad H, Maleki-Hajiagha AJJomcr. Ovarian mature cystic teratoma with malignant transformation: two case reports. 2021;15:1-6.

14. Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, et al. Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium. 2021;39(14):1563-74.

15. Chen J, Li Y, Wu J, Liu Y, Kang SJBor. Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors. 2021;105(1):164-78.

16. Ayyanar P, Begum J, Rout S, Mishra PJIJoP, Microbiology. Synchronous colonic adenocarcinoma and well-differentiated neuroendocrine tumor arising in a mature cystic teratoma of ovary---Rare presentation in a postmenopausal woman with literature review. 2021;64(2):385-9.

17. Gritsch S, Batchelor TT, Gonzalez Castro LNJC. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. 2022;128(1):47-58.

18. Sakuma T, Aoki K, Ando M, Inaoka K, Ito T, Yamashita KUCR. Testicular metastasis of colon cancer masquerading a hydrocele of testis. 2021;39:101868.

19. Kasahara M, Shimizu T, Aoki H, Okawa M, Yamabe F, Kobayashi H, et al. Colon cancer metastasis to the right testis: case report and review of literature. 2022;2022(1):2649259.

20. Schroeder T, Plambeck B, Bowdino C, DiMaio D, Christiansen AJC. Metastasis of Rectal Adenocarcinoma to the Penis and Scrotum in an Adult. 2021;13(10).

21. Wu J-M, Zhang A, Dong Y, Lin S-H, Meng J-C, Fang C-TJM. Colorectal cancer with testicular metastasis: A case report and literature review. 2023;102(11):e33214.

22. Yuan Y, Li H, Yang HJIJoP, Microbiology. Clinicopathological observation of mature teratoma with malignant transformation, a single center retrospective study. 2022;65(2):369-73.

23. Elagi D, Young R, Dayili AJUA. Malignant transformation of testicular teratoma to primitive neuroectodermal tumor. 2022;14(4):403-6.

24. Pašalić IM, Sabol M, Prtenjača E, Solomun LP, Pavić MJEJoSO. Mature cystic teratoma and their malignant transformation. 2025:109641.

25. Atwi D, Kamal M, Quinton M, Hassell LAJJoO, Research G. Malignant transformation of mature cystic teratoma of the ovary. 2022;48(12):3068-76.

26. Li X, Tang X, Zhuo WJAoPM. Malignant transformation of ovarian teratoma responded well to immunotherapy after failed chemotherapy: a case report. 2021;10(7):8499505-8505.

27. Gogusev J, Lepelletier Y, Cohen H, Ami O, Validire PJIJoMS. Idiopathic Abdominal Wall Endometrioma: Case Report with Investigation of the Pathological, Molecular Cytogenetic and Cell Growth Features In Vitro. 2025;26(2):775.

28. Cheng Y, Bai Q, Wu B, Chang B, Bi R, Yang W, et al. Clinicopathologic and molecular cytogenetic analysis of 8 cases with uterine cervical Ewing sarcoma: case series with literature review. 2021;45(4):523-30.

29. Fan J, Guan Y, Guo CC, Wang GJJoC, Pathology T. Testicular germ cell tumors with somatic-type malignancy. 2023;3(1):35-42.

30. Guo CC, Czerniak BJHP. Somatic-type malignancies in testicular germ cell tumors. 2022;127:123-35.

31. Acosta AM, Al-Obaidy KI, Sholl LM, Dickson BC, Lindeman NI, Hirsch MS, et al. Sarcomatoid yolk sac tumor harbors somatic mutations that are otherwise rare in testicular germ cell tumors. 2022;46(5):701-12.

32. Farag CM, Johnston EK, Antar RM, Issa SG, Gadiwalla Q, Tariq Z, et al. Unveiling the genomic landscape of possible metastatic malignant transformation of teratoma secondary to cisplatinchemotherapy: a Tempus gene analysis-based case report literature review. 2023;13:1192843.

33. MacAskill FJCCiUS. 20 Metastatic post-chemotherapy testicular residual cancer: mass and cancer survivorship. 2022:199.


Review

For citations:


Ben Ghashir N., Babitha A., Chehal A., ALakkad A. Pure Adenocarcinoma with Intestinal Differentiation of The Testis as The First Presentation of a Testicular Teratoma: A Case Report with Literature Review of Management. The Russian Archives of Internal Medicine. 2026;16(2):137-144. https://doi.org/10.20514/2226-6704-2026-16-2-137-144. EDN: RXLWMO

Views: 209

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2226-6704 (Print)
ISSN 2411-6564 (Online)